In people with type 2 diabetes fasting during Ramadan, liraglutide led to significant weight loss compared with sulphonylureas in a meta-analysis (-1.81 kg).
In plain wordsIn people with type 2 diabetes fasting during Ramadan, liraglutide led to more weight loss than sulphonylureas.
- Peptide
- Liraglutide
- Outcome
- DecreaseWeight change during Ramadan
- Study
n: not reported in source
- Comparator
- Sulphonylureas
- Outcome group
- Body weight · Metabolic and weight
- Studied dose
- Dose not stated
Measurements
- Weight change
- −1.81 kg
- liraglutide versus sulphonylureas
Source sentences
The use of liraglutide led to significant weight loss (-1.81 kg, 95% CI -2.91, -0.71; p = 0.001) compared with sulphonylureas.
2 context sentences(design, population, supporting numbers)
Electronic databases were searched for randomized controlled trials (RCTs) and observational studies that compared non-insulin glucose-lowering agents in people with type 2 diabetes fasting during Ramadan.
A total of 16 studies were included: 9 RCTs and 7 observational studies.